Related Experiment Video
Updated: Oct 27, 2025

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Association of Chronic Liver Disease and Mortality in Patients With Aneurysmal Subarachnoid Hemorrhage
Yu Zhang1, Linjie Li1, Lu Jia1
1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China (Y.Z., L.L., L.J., C.Y., Y.C., F.F.).
Insights
Chronic liver disease (CLD) significantly increases mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). A high Model for End-Stage Liver Disease score further elevates mortality risk in these patients.
Area of Science:
- Neurology
- Hepatology
- Critical Care Medicine
Background:
- Chronic liver disease (CLD) is a known risk factor for poor outcomes in critically ill patients.
- The impact of CLD on mortality in aneurysmal subarachnoid hemorrhage (aSAH) patients is not well understood.
Purpose of the Study:
- To investigate the association between CLD and in-hospital mortality in patients with aSAH.
- To determine if liver disease severity, using the Model for End-Stage Liver Disease (MELD) score, influences mortality in aSAH patients with CLD.
Main Methods:
- Retrospective cohort study of 6228 aSAH patients admitted between 2009 and 2019.
- Propensity score matching was used to compare mortality between aSAH patients with and without CLD.
- Analysis of the association between MELD score and mortality within the CLD subgroup.
Main Results:
- A total of 489 (7.9%) aSAH patients had CLD.
- CLD was significantly associated with increased in-hospital mortality in aSAH patients (OR, 2.04; 95% CI, 1.43–2.92).
- In aSAH patients with CLD, a higher MELD score correlated with increased mortality risk.
Conclusions:
- CLD is an independent risk factor for increased mortality in aSAH patients.
- Liver disease severity, indicated by MELD score, is crucial for predicting outcomes in aSAH patients with CLD.
Background And Purpose:
Chronic liver disease (CLD) is a risk factor for increased morbidity and mortality in acutely ill patients. For patients with aneurysmal subarachnoid hemorrhage (aSAH), the association between CLD and mortality remains unknown.
Methods:
In this retrospective cohort study, we analyzed consecutive aSAH patients admitted to the West China Hospital between 2009 and 2019. The primary outcome was in-hospital all-cause mortality.
Results:
This study included 6228 cases of aSAH, 489 (7.9%) of whom also had CLD. In a propensity-matched analysis, CLD was associated with increased mortality in patients with aSAH compared with non-CLD (odds ratio, 2.04 [95% CI, 1.43–2.92]). In aSAH patients with CLD, a high Model for End-Stage Liver Disease score was still associated with an increased odds of mortality.
Conclusions:
Among aSAH patients, CLD was associated with increased mortality compared with non-CLD. Among aSAH patients with CLD, a higher Model for End-Stage Liver Disease score was associated with an increased odds of mortality.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

